Cerevance to Participate in the TD Cowen Treatment Advancements in Obesity and Related Disorders Summit
Cerevance to Participate in the TD Cowen Treatment Advancements in Obesity and Related Disorders Summit GlobeNewswire November 17, 2025 BOSTON, Nov. 17, 2025 (GLOBE NEWSWIRE) — Cerevance, a clinical-stage biopharmaceutical company advancing multiple cell type-specific therapies for the treatment of neurodegenerative diseases and obesity, today announced participation in a panel discussion at the TD Cowen […]